The following webcasts are scheduled. Participation is free, so please register to participate.
Please be aware that Webinars are hosted through GoToWebinar. If you are not already set up to view webinars through this service, please allow 5 minutes before the start of the webinar to establish access.
Date: September 30th, 2014 16: 00-16: 30 GMT (London time)
Horizon provides in-vitro assay development and drug screening services powered by our precision gene-editing, human isogenic cell-line platforms and disease microenvironment assays. To date we have successfully completed well over 300 pharma, biotech and academic clients. Join us to learn how we can support and drive your research programs using our isogenic cell-line based patient models knockdown/ knockout studies, 3D assay formats, siRNA/sgRNA screening services and many other tools and capabilities.
Date: October 21st, 2014 16: 00-16: 30 GMT (London time)
Genomic advances in preceding decades have led to a wealth of information on the genetic basis of disease. One way to leverage this information is through development of in vitro cell line models in which patient-relevant mutations are precisely recapitulated, allowing novel drug target identification and validation, and the realisation of personalised therapies. In this webinar we discuss Horizon’s gene-editing platform GENESIS and our custom cell line development service, including: -Selecting the right tool for the right targeting outcome -Systematic optimisation of the GENESIS platform -Combining CRISPR, ZFNs and rAAV technologies to improve targeting efficiency -Advanced experimental design for knock-ins
Paragraph explaining benefits of Biocair×